1) Diabetic cardiomyopathy
糖尿病性心肌病变
1.
Diabetic cardiomyopathy was showed by electron micrographs.
目的 研究高压氧治疗 (HBOT)是否可改善链脲佐菌素 (STZ)大鼠的糖尿病性心肌病变。
2) diabetic cardiomyopathy
糖尿病心肌病变
1.
Objective To explore how does chymase affect diabetic cardiomyopathy by investigating the gene expression of chymase and the relationship between the gene expression of chymase and the angiotensin Ⅱ in the cardiomyopathy of streptozotocin-induced diabetic hamasters.
结论存在糖尿病心肌病变的仓鼠心肌中,chymase mRNA表达水平以及AngⅡ含量显著升高,可能是导致心肌Ⅰ、Ⅲ型胶原沉积、心肌细胞凋亡等心肌病变的重要原因。
2.
Purpose To investigate the therapeutic value and possible mechanism of astragalus polysaccharide(APS) for the treatment of diabetic cardiomyopathy.
结论APS可以抑制糖尿病心肌中chymanse依赖性AngⅡ的生成,起到对糖尿病心肌病变的保护作用。
3.
Diabetic cardiomyopathy is a kind of cardiac disease except of other complications such as hypertension, coronary artery disease.
糖尿病心肌病变是一种独立于其它心血管并发症如高血压、冠心病之外的心脏病,氧化应激主导了糖尿病心肌病变的发病过程。
3) Diabetic cardiomyopathy
糖尿病性心肌病
1.
Expression of energy metabolism-related genes in myocardial tissues of rats with diabetic cardiomyopathy;
糖尿病性心肌病大鼠心肌组织中能量代谢相关基因的表达及其意义
2.
Correlation between GLP-1 and CRP in patients with diabetic cardiomyopathy
糖尿病性心肌病患者GLP-1与C-反应蛋白的相关性分析
3.
Effect of astragalus injection on adhesion molecule and C-reactive protein in patients with diabetic cardiomyopathy
黄芪注射液对糖尿病性心肌病患者血清黏附分子及C反应蛋白的影响
4) diabetic cardiomyopathy
糖尿病心肌病
1.
Effects of gypenosides on cardiac function in diabetic cardiomyopathy rats;
绞股蓝总苷对糖尿病心肌病大鼠心脏功能的影响
2.
A method to produce the animal model of diabetic cardiomyopathy;
建立糖尿病心肌病动物模型方法的实验研究
3.
An analysis of clinical characteristic about diabetic cardiomyopathy;
糖尿病心肌病临床特点分析
5) Diabetic cardiomyopathy (DCM)
糖尿病心肌病(DCM)
补充资料：糖尿病非酮症性高渗性昏迷
糖尿病非酮症性高渗性昏迷
diabetic hyperosmolar nonketotic coma
糖尿病患者由于感染、尿毒症、电解质紊乱、甲亢、尿崩症等原因使血糖升高引起渗透性利尿，细胞内失水，特别是脑细胞可引起昏迷和死亡。特点起病慢，常被诱发本病的疾病或伴随症状所掩盖。早期呈原有糖尿病症状加重，嗜睡，逐渐进入昏迷状态。血糖＞28～54mmol/L，血钠＞145mmol/L，血浆渗透压＞310mmol/L，血、尿酮体无明显增高，无酸中毒。用等渗液或低于血浆渗透压40mmol/L的高渗液治疗，予以小剂量胰岛素，防止因血糖降低使血浆渗透压下降过快引起脑水肿。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条